News

Merck, known as MSD outside the United States and Canada, has announced positive results from its Phase 3 KEYNOTE-C93 clinical trial evaluating KEYTRUDA (pembrolizumab) as a first-line…
Read More...

Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to its supplemental Biologics License Application (sBLA) for Gazyva/Gazyvaro…
Read More...

Harbour BioMed and Kelun-Biotech have announced that China's National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for…
Read More...

Takeda has announced a long-term collaboration with the Indonesian government to strengthen the country's plasma collection and manufacturing capabilities, with the aim of improving…
Read More...

Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of SBT-77-7101, an investigational regulatory T cell (Treg) therapy being developed…
Read More...

Novartis has entered into a new collaboration with artificial intelligence company Chai Discovery to accelerate the discovery of therapeutic antibodies using advanced AI technology. The…
Read More...

AstraZeneca has signed an exclusive licensing agreement with China's Dizal Pharmaceutical Co., Ltd. to acquire the worldwide rights to develop and commercialize Zegfrovy…
Read More...

Roche has received CE Mark certification for its Elecsys IGRA TB test, a new blood-based diagnostic designed to identify tuberculosis infection, also known as latent tuberculosis, in…
Read More...

Teva Pharmaceuticals International GmbH has entered into a global licensing agreement with Polpharma Biologics International AG for exclusive commercialization rights to Polpharma…
Read More...

Samsung Bioepis Co., Ltd. has entered into a licensing agreement with Proteina Co., Ltd. to support the development of artificial intelligence-based antibody therapeutics under a…
Read More...

Evogene has partnered with Tel Aviv University’s Blavatnik Center for Drug Discovery to establish a joint initiative aimed at accelerating small-molecule drug discovery programmes…
Read More...

AstraZeneca and Ionis Pharmaceuticals have announced that their Phase III CARDIO-TTRansform trial evaluating Wainua (eplontersen) in patients with transthyretin-mediated amyloid…
Read More...

OTR Therapeutics has entered into a strategic collaboration with LG Chem to identify, evaluate and develop novel oncology assets originating from China, as both companies seek to expand…
Read More...

Bayer has formed a strategic clinical trials alliance with the University of Colorado Anschutz, UCHealth and Children’s Hospital Colorado, marking the company’s first collaboration of…
Read More...

Certara, Inc. has announced a collaboration with NVIDIA aimed at expanding the use of agentic artificial intelligence across drug discovery and development workflows. The partnership…
Read More...

Cyllene Therapeutics has closed a €33 million Series C financing round to advance clinical development of its lead DNA medicine candidate, EG110A, for severe neurogenic bladder…
Read More...

Biocytogen and Whitehawk Therapeutics have entered into a global collaboration to develop bispecific antibody-drug conjugates, expanding efforts to apply dual-targeting antibody…
Read More...

Vanda Pharmaceuticals has received Rare Pediatric Disease Designation from the US Food and Drug Administration for VCA-894A, an investigational antisense oligonucleotide therapy being…
Read More...

Vivani Medical has entered into a new agreement with Novo Nordisk that will allow the Danish drugmaker to evaluate Vivani’s NPM-139 semaglutide implant, a long-acting treatment…
Read More...

Biocytogen and Whitehawk Therapeutics have entered into a global collaboration to develop bispecific antibody-drug conjugates, or BsADCs, for cancer treatment. Under the agreement,…
Read More...